Pulmonary arterial hypertension (PAH) is a progressive disease caused by a variety of pulmonary and/or cardiac disorders. PAH is commonly characterized by an increase in the pulmonary vascular resistance or in the right ventricular systolic pressure (RVSP). A rise in RVSP induces the right ventricular (RV) hypertrophy, and RV failure, and may eventually lead to premature death. It is well known that a single subcutaneous administration of a pyrrolizidine alkaloid monocrotaline (MCT) to rats causes cardiovascular and pulmonary disorders similar to those in patients with PAH 1,2) including severe RV hypertrophy 3, 4) and RV failure. [5] [6] [7] [8] Despite extensive studies, serial events of MCT-induced functional changes in the development and progression of RV failure have not been fully elucidated.
Pulmonary arterial hypertension (PAH) is a progressive disease caused by a variety of pulmonary and/or cardiac disorders. PAH is commonly characterized by an increase in the pulmonary vascular resistance or in the right ventricular systolic pressure (RVSP). A rise in RVSP induces the right ventricular (RV) hypertrophy, and RV failure, and may eventually lead to premature death. It is well known that a single subcutaneous administration of a pyrrolizidine alkaloid monocrotaline (MCT) to rats causes cardiovascular and pulmonary disorders similar to those in patients with PAH 1, 2) including severe RV hypertrophy 3, 4) and RV failure. [5] [6] [7] [8] Despite extensive studies, serial events of MCT-induced functional changes in the development and progression of RV failure have not been fully elucidated.
The present study was designed to elucidate pathophysiological and pharmacological alterations of the RV function of MCT administered rats. To examine time-matched alterations of the RV function of MCT administered animals, we focused on the time course of study on cardiac function by a noninvasive echocardiography in rats.
MATERIALS AND METHODS

Animals
Male Wistar rats (SLC, Hamamatsu, Japan) weighting 190-210 g were used in the present study. Rats were randomly selected to receive a subcutaneous injection of either monocrotaline (MCT, 60 mg/kg) or an equal volume of saline (CON). The animals were conditioned according to Guide for the Care and Use of Laboratory Animals as published by the U.S. National Institutes of Health (NIH Publication No. 85-23, revised 1996) . The protocol of this study was approved by the Committee of Animal Use and Welfare of Tokyo University of Pharmacy and Life Sciences.
Echocardiography Transthoracic echocardiography was performed on rats according to the method described previously, 9) in which experimental conditions employed, including appropriate anesthesia, were extensively examined. In the present study, rats were evaluated 2, 4, 6, and 8 weeks after administration of either MCT (2w-, 4w-, 6w-, and 8w-MCT rats) or vehicle (2w-, 4w-, 6w-, and 8w-CON rats, respectively).
The animals were anesthetized with 40 mg/kg intraperitoneally (i.p.) pentobarbital sodium, and then their hairs on the chest were shaved before examination. Two-dimensional and Doppler imaging were performed by using ProSound 5500 R (Aloka, Tokyo, Japan) with a 10-MHz transducer. The transthoracic echocardiographic probe was placed to obtain long-axis and apical four-chamber views. To evaluate right ventricular (RV) function, cardiac output (CO) and stroke volume (SV) at the pulmonary artery and the RV Tei index were measured. After determination of the pulmonary arterial flow, heart rate (HR), velocity time integral (VTI), and pulmonary arterial diameter (PAD) were measured by the long-axis view. The ratios of CO and SV to body weight (BW) were calculated according to the following equations (CO and SV indices (COI and SVI), respectively) 9,10) : COIϭ(PAD/2) 2 ϫpϫVTIϫHR/BW, SVIϭCO/(HRϫBW). In addition, to characterize the pulmonary outflow, pulmonary artery flow acceleration time (PAAT) was measured. PAAT was estimated as the difference between the time at which the systolic blood flow begins to increase and the time at which the peak velocity of the pulmonary outflow is attained.
11) The RV Tei index, which was defined below, was assessed from Doppler recordings of the RV inflow and outflow. From tricuspid inflow in the apical four-chamber view, the time interval from the cessation to the onset of tricuspid inflow was measured (a-interval). Ejection time (b-interval) was measured from the RV outflow velocity curve recorded in the long-axis view. The RV Tei index, which increase is considered to be a sign of RV dysfunction, was calculated as (aϪb)/b. 12, 13) Then, 10 consecutive cardiac cycle images were measured and averaged.
Tissue Weight and Histological Study After measurement of cardiac and hemodynamic parameters by the echocardiography, the heart was isolated and dissected free from the atria, aorta, and pulmonary artery, and the free wall of the right ventricle was separated from the left ventricle (LV) and septum (Sep) and then weighed. The ratio of RV weight to (LVϩSep) weight (RVW/(LVWϩSepW)) was calculated to assess RV hypertrophy. 14) RV and lung weights were measured and their ratios to the BW were calculated.
The other hearts were transversely sectioned, fixed in 4% paraformaldehyde for 24 h at 4°C, and subsequently embedded in paraffin. To evaluate fibrotic changes of the heart, tissue sections were stained with Masson's trichrome. Paraffinembedded tissue blocks were sectioned at 3 mm. Masson's trichrome staining was performed by the standard technique.
Measurement of Contractile Force of Isolated Right Ventricular Preparation
For the measurement of RV contractile force, coronary-perfused RV muscles were prepared from MCT and CON rat hearts according to the method described previously. 15) At 0, 2, 4, 6, and 8 weeks after MCT or vehicle administration, the rats were anesthetized with 40 mg/kg pentobarbital, i.p., and then, their hearts were isolated. A cannula was placed in the aorta of isolated hearts. The left coronary artery was sutured, and then the left atrium, ventricle, and septum were eliminated. The RV wall and right atrium was perfused at 37°C with a constant flow rate (3.0 ml/min) of the Krebs-Henseleit bicarbonate buffer of the following composition (mM): NaCl, 120; KCl, 4.8; KH 2 PO 4 , 1.2; MgSO 4 , 1.2; CaCl 2 , 1.25; NaHCO 3 , 25; and glucose, 11 (pH 7.4). The perfusion buffer was equilibrated with a gas mixture of 95% O 2 ϩ5% CO 2 . The RV wall apex was attached to a force displacement transducer (TB-611T, Nihon Kohden, Tokyo, Japan) in an organ bath. The initial resting tension on each preparation was adjusted to 0.5 g. All preparations had been allowed to equilibrate for 30 min before the agents were applied. We estimated the basal values for cardiac double product as RV workload by multiplying HR with developed tension of the right ventricle in the time course study, 16) whereas we focused on changes in pharmacological responses of the RV muscle to cardiotonic agents in the pharmacological study as described below.
Pharmacological Study After 30 min of equilibrated perfusion of the perfused right ventricle with the KrebsHenseleit solution, basal values for cardiac and hemodynamic parameters including developed tension, HR, and double product of the perfused RV muscles were determined. Then, dobutamine, colforsin daropate, and acetylcholine (ACh) at bolus doses of 100 ng, 1 mg, and 1 mg, respectively, were infused into the infusion inlet located just prior to the cannula of the coronary artery. In a preliminary study, we examined the response of cardiac double product of the perfused RV muscles of CON rat hearts to different doses of dobutamine (10 to 300 ng) and colforsin daropate (0.1 to 3 mg). We found that about half maximal values for the Ddouble product (dobutamine or colforsin daropate-induced changes in the maximal value of double product) were obtained by the doses employed in the present study. We also examined the dose-dependent effects of ACh (30 to 3000 ng) on the periods for cardiac arrest and for bradycardia of the RV muscle of the CON rat in a preliminary study and found that half maximal value of the period for bradycardia in the perfused RV muscle was obtained by injection of 1 mg of ACh, whereas this dose of ACh prolonged the period for cardiac arrest of the RV muscle to a little degree.
Statistics The results were expressed as meansϮS.E.M. Statistical significance of differences in echocardiographic parameters and dose-dependent effects of ACh was estimated using 2-way ANOVA for repeated measures. Statistical significance of differences in tissue weight, RV contractile force, and pharmacological response to cardiotonic agents was estimated using 2-way factorial ANOVA followed by Fisher's PLSD correction for multiple pairwise comparisons. Differences with a probability of 5% or less were considered to be significant (pϽ0.05).
RESULTS
Time Course of Changes in Tissue Weight and the Related Parameters
The time course of changes in body, heart, RV, and lung weights of the rats and the parameters related to them are shown in Table 1 . The BW of the 4w-, 6w-, and 8w-MCT rats was significantly lighter than that of the CON rat. The ratio of heart weight (HW)/BW of the MCT rat was significantly higher at the 4th week and markedly higher at the 6th and 8th weeks. The RVW and the ratios of RVW/BW of the 6w-and 8w-MCT rat were significantly greater than those of the CON rats. As shown in Fig. 1 , the RVW/(LVWϩSepW), a body weight-independent index of RV hypertrophy, of the 6w-and 8w-MCT rats were significantly greater than that of the CON rat. The lung weight (LungW) and the ratio of LungW/BW of the 4w-, 6w-and 8w-MCT rats were significantly greater than those of the CON rats (Table 1) .
Histological Study The RV muscles of 6w-CON and 6w-MCT rats were stained with the Masson's trichrome staining (Fig. 2) . Apparent fibrosis in the RV muscle of the 6w-MCT rat was seen.
Echocardiographic Parameters Figure 3A shows a transverse section (B-mode) of the heart, left ventricle, and right ventricle of the 6w-CON and 6w-MCT rats. A marked dilation of the RV cavity of the 6w-MCT rat was seen. Figure  3B shows the image of the pulmonary arterial flow (D-mode) of the 6w-CON and 6w-MCT rats. The midsystolic notch in the pulmonary arterial flow waveform was detected in the echocardiographic image of the 6w-MCT rat. The time course of changes in serial parameters indicates the pathophysiological alterations of the MCT rat. PAAT, an estimate of the pulmonary arterial systolic pressure (PASP), was decreased at the 2nd to 8th weeks after the MCT administration, and was declined with time after MCT administration (Fig. 3C) . COI (Fig. 3D) and SVI (Fig. 3E) were decreased along with a decrease in HR (Fig. 3F) at the 6th and 8th weeks. The RV Tei index (Fig. 3G) , which increase results from the development of RV dysfunction and provides prognostic information for a variety of myocardial conditions, was increased at the 6th to 8th weeks after MCT administration as compared with those of the corresponding CON rats.
Basal Values for Cardiac Double Product of the CON and MCT Rats To elucidate MCT-induced alterations in RV function of the rats, cardiac double product (developed tensionϫHR), a cardiac workload, of isolated perfused RV muscle was determined. The time course of changes in the basal values for developed tension, HR, and cardiac double product of the CON and MCT rats from the onset to the 8th week after MCT administration are shown in Fig. 4 . The basal developed tension (Fig. 4A), HR (Fig. 4B) , and cardiac double product (Fig. 4C ) of the RV muscle of naïve rat was 1.54Ϯ0.04 g, 253Ϯ12 beats/min (bpm), and 390Ϯ24 g · bpm, respectively (nϭ5). The basal values for developed tension, HR, and double product of the RV muscle of the MCT rat were not altered at the 2nd and 4th weeks. On the other hand, the basal developed tensions of both 6w-and 8w-MCT rats were significantly decreased to approximately 80% of the CON rats (Fig. 4A) . The basal HR of the 6w-and 8w-MCT rats was significantly decreased to approximately 60% and 50% of the corresponding CON rats, respectively (Fig. 4B) . The basal double product of the 6w-and 8w-MCT rats was significantly decreased to approximately 50% and 40% of the corresponding CON rats, respectively (Fig. 4C) .
Contractile Force and Response to Cardiotonic Agents of Isolated Right Ventricle of the 6w-CON and 6w-MCT
Rat Pharmacological responses of the RV muscle preparations of the MCT and CON rats to dobutamine, a selective b 1 -adrenoceptor stimulant, and colforsin daropate, a watersoluble analogue of forskolin that directly stimulates adenylate cyclase, were examined (Figs. 5, 6, respectively, nϭ5) .
The representative tracings of the effect of dobutamine on the developed tension, HR, and double product of the isolated perfused RV muscle are shown in Fig. 5A . Treatment of the 6w-CON rat with dobutamine markedly augmented the developed tension, HR, and double product followed by a gradual recovery to the baseline values. In contrast, injection of dobutamine into the RV muscle of the 6w-MCT rats transiently augmented the developed tension and double product, followed by sustained reduction in the developed tension below the baseline value despite a sustained increase in HR.
To elucidate when such reduction in the developed tension provokes, dobutamine-induced changes in the maximal value of double product (Ddouble product) of the RV muscles of the 2w-to 8w-MCT rats and the corresponding CON rats were determined (Fig. 5B) . No significant differences in the Ddouble product of the right ventricle between the 2w-MCT and 2w-CON rats or between the 4w-MCT and 4w-CON rats. The dobutamine-induced decrease in Ddouble products of the 6w-and 8w-MCT rats reached to approximately 25% of the CON rats. Figure 6A shows the representative tracing of the effect of colforsin daropate on developed tension, HR, and double product of the isolated perfused RV muscles of the 6w-MCT and 6w-CON rats. Sustained increases in the developed tension, HR, and double product were observed in the 6w-CON rats after infusion of colforsin daropate. A transient positive inotropic effect of the 6w-MCT rat was detected immediately after the injection of colforsin daropate, followed by the negative inotropic effect and a sustained increase in HR. Figure  6B shows the time course of colforsin daropate-induced changes in the Ddouble product of the RV muscle of the 2w-to 8w-MCT and the corresponding CON rats. There were no significant differences in the Ddouble product between the 2w-MCT and 2w-CON rats or between the 4w-MCT and 4w-CON rats. The colforsin daropate-induced decrease in the Ddouble products of both 6w-and 8w-MCT rats reached to approximately 30% of the corresponding CON rats.
In the next pharmacological study, the effect of ACh on the RV muscle was determined. As well known, ACh exerts negative chronotropic and inotropic effects on the heart muscle. As shown in Fig. 7A , ACh decreased the developed tension of the RV muscle of the 6w-CON rat transiently, whereas it did not appear in the 6w-MCT rat. ACh also provoked bradycardia and eventually cardiac arrest of the RV muscle of the 6w-CON rat. ACh-induced negative inotropic action of the RV muscle of the 6w-CON rat was seen during the recovery period after cardiac arrest, whereas those of the 6w-MCT rat appeared to be very weak (Fig. 7A) . The periods for bradycardia and cardiac arrest of the 6w-MCT rat were prolonged in a dose-dependent manner, as compared with those of the CON rat (Figs. 7B, C) .
The time course of 1 mg ACh-induced changes in the periods for cardiac arrest (Fig. 7D ) and for bradycardia (Fig. 7E) of the RV muscles of the 2w-to 8w-MCT rats showed significant differences in these periods between the CON and MCT rats at the 6th and 8th weeks after the MCT administration.
DISCUSSION
In the present study, we observed significant increases in the RVW, RVW/BW, and RVW/(LVWϩSepW) along with time after MCT administration. Since the ratio of RVW/ (LVWϩSepW) is considered to be a marker of RV hypertrophy, 14) augmentation of this ratio may represent the genesis of RV hypertrophy after MCT administration, as similar to 1382 Vol. 32, No. 8 that reported by others. 17, 18) The Masson's trichrome staining of the 6w-MCT rats showed a marked interstitial fibrosis in the right ventricle, which was responsible for the increase in the RVSP along with time after MCT administration. It is apparent that cardiac hypertrophy and fibrosis in the myocardium is a possible cause for cardiac dysfunction. 9, [19] [20] [21] [22] [23] [24] [25] Several studies have shown morphologic and hemodynamic alterations in cardiac function of MCT rats including an increase in the RV systolic time intervals, 26) changes in PAAT and RV free wall thickness, 11) and the dilation of RV cavity 11, 27) associated with a decrease in RV fractional shortening. 18) However, satisfactory data in terms of time-dependency of pathophysiological alterations in cardiac function, particularly in the RV function along with the progress of functional alterations in small animals remain to be elucidated. We focused on the time course study on changes in the whole heart and RV function via the pulmonary arterial flow by using the color Doppler method in the echocardiography to elucidate cardiac and circulatory alterations related to the RV hypertrophy and failure.
Dilation of the RV cavity and flattening of the LV cavity were observed in the 6w-and 8w-MCT rats, which were associated with PAH and an increase in the RVSP at these periods. We observed a time-deperdend decrease with administration in the PAAT in the MCT rat. Since PAAT is found to be an early event in the development of PAH and is a measure that is most closely correlated with an increased PASP, this parameter can be used for estimation of PASP in this model. 11) Thus, it is likely that PASP and RVSP may be augmented soon after MCT administration. The COI and SVI of the 6w-and 8w-MCT rats were decreased, suggesting the genesis of heart failure in this model. The RV Tei index is used for the assessment of RV dysfunction in patients with PAH. 13, 28, 29) Thus, we used Tei index to be a marker for cardiac dysfunction. The RV Tei index of the 4w-to 8w-MCT rats was increased, suggesting that normal RV function was maintained until the 4th week, but was aggravated thereafter. We also found that the basal cardiac double product, a measure of myocardial workload, 16) of isolated perfused RV muscles was decreased at the 6th and 8th weeks after the MCT administration. The present echocardiographic study supported the idea that MCT administration induced sustained PAH, which results in a rise in RVSP, followed by progression or development of RV hypertrophy and RV dysfunction.
The time course study on the developed tension, HR, and basal cardiac double product showed no changes in the parameters during 2nd to 4th weeks after the MCT administration, whereas the those of the MCT rat was markedly decreased at the 6th and 8th weeks. Thus, it is likely that profound pathogenesis in the RV function occurs from the 4th to 6th weeks after MCT administration. This idea is comparable with the changes in the echocardiographic parameters examined, such as a dilation of RV cavity, an increase in RV Tei index, and decreases in COI and SVI of the MCT rat.
A marked positive inotropy of the RV muscle upon treatment with dobutamine and colforsin daropate is a common pharmacological response. In contrast, it may be abnormal that a marked decrease in the Ddouble product, which was associated with a significant decline in the developed tension, was observed in the RV muscle of the 6w-and 8w-MCT rats upon treatment with dobutamine or colforsin daropate. Several possible mechanisms for this alteration could be considered in terms of mechanical, metabolic, and signal transductional impairment. Fibrosis, as was observed by the Masson's trichrome staining, may be a plausible cause for the RV dysfunction. It might be possible to have an idea that myocardial energy levels play a role in the cardiac function under enhanced adenylate cyclase activity, although no evidence has been reported so far. Several investigators have postulated that a decreased activation of b 1 -adrenoceptor/adenylate cyclase system of the RV muscle is involved in the genesis of RV hypertrophy and RV failure in MCT rats. 5, 7, 17, [30] [31] [32] Further information concerning the contribution of the adenylate cyclase system to the abnormal response of cardiostimulants is awaited.
We observed that the isolated perfused RV muscle of the 6w-MCT rats elicited a sustained negative inotropy following a transient increase in the developed tension upon treatment with dobutamine or colforsin daropate. In addition, the basal value for the double product of the 6w-MCT rats was very low and the pattern of the activation of the adenylate cyclase system was definitely different from that of the corresponding CON rats, suggesting the possibility that the contractile machinery for the RV muscle is seriously injured in terms of mechanical failure in cardiac muscle, biochemical impairment, and failure in the linkage of signal transduction in cardiac muscle. In this context, Hasenfuss et al. 33) and Kogler et al. 7) have shown the genesis of down-regulation of Ca 2ϩ modulated proteins in the sarcoplasmic reticulum membrane of the MCT-administered rat heart. We also observed prolongation of the periods for cardiac arrest and bradycardia of the RV muscles of the 6w-and 8w-MCT rats. Few reports are available concerning the effects of ACh on the MCT rat. It is observed that the numbers of M 2 receptors as well as in the amounts of Gi proteins in the right ventricle in MCT rats were similar to those in control rats. 5) In contrast, M 2 receptors in the right atrium have been shown to be up-regulated. 34 ) The former appears to be incompatible to our findings and the latter might be compatible with our findings, but more close correlation should be elucidated for understanding of the mechanism responsible for the effect of ACh on the right ventricle of the MCT-administered rat. Furthermore, the reduced levels of cholinesterase activity in the RV muscle of the MCT rats are possible factor for the ACh hypersensitivity. However, we did not determine changes in the enzyme activity in the present study. Further experiments are required to elucidate this possibility.
In summary, we demonstrated the time course study on the pathophysiological alterations in the process generating RV dysfunction in the MCT-administered rat on the basis of histological and echocardiographic data. We also showed abnormal responses of the RV muscle preparation isolated from the MCT rat to adenylate cyclase activators and ACh. Although the exact mechanisms for these alterations remain unclear, the present study provided the possible process of the pathophysiological alterations initiated by MCT-induced PAH.
